2025 FDA People Management 
The Checkup by Singlecare
APRIL 24, 2025
It is approved by the Food and Drug Administration (FDA) for treating Type 2 diabetes. As a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, it helps people manage their blood sugar levels. Mounjaro (tirzepatide) is a prescription drug developed by Eli Lilly.
Pharmacy Times
JULY 15, 2025
PillPack from Amazon Pharmacy has expanded access to Medicare Part D patients across the country, and this is huge because it means that millions of people managing multiple chronic conditions—and therefore juggling multiple medications—now have access to this service. It's exciting.
Expert insights. Personalized for you.
Let's personalize your content